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Depletion of Ca2+ from the endoplasmic reticulum (ER) lumen triggers the opening of Ca2+ release-
activated Ca2+ (CRAC) channels at the plasma membrane. CRAC channels are activated by stromal
interaction molecule 1 (STIM1), an ER resident protein that senses Ca2+ store depletion and interacts
with Orai1, the pore-forming subunit of the channel. The subunit stoichiometry of the CRAC channel
is controversial. Here we provide evidence, using atomic force microscopy (AFM) imaging, that Orai1
assembles as a hexamer, and that STIM1 binds to Orai1 with sixfold symmetry. STIM1 associates with
Orai1 in the form of monomers, dimers, and multimeric string-like structures that form links
between the Orai1 hexamers. Our results provide new insights into the nature of the interactions
between STIM1 and Orai1.
Structured summary of protein interactions:
Orai1 physically interacts with STIM1 by anti tag coimmunoprecipitation (View interaction)
Orai1 and STIM1 bind by atomic force microscopy (View interaction)
STIM1 and Orai1 colocalize by ﬂuorescence microscopy (View interaction)
STIM1 and STIM1 bind by atomic force microscopy (1, 2)
Orai1 and Orai1 bind by atomic force microscopy (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Depletion of Ca2+ within the lumen of the endoplasmic reticu-
lum (ER) triggers Ca2+ inﬂux across the plasma membrane (PM)
via Ca2+ release-activated Ca2+ (CRAC) channels [1,2]. This process
of store-operated Ca2+ entry involves two key proteins, stromal
interacting molecule (STIM), an ER resident protein [3,4], and Orai,
which forms the CRAC channel at the PM [5–7]. Activation of the
CRAC channel occurs when STIM senses depletion of the ER Ca2+
store, oligomerizes and translocates to ER-PM junctions, where it
binds to and activates Orai [8].
Each human Orai1 subunit has four putative transmembrane a-
helices (M1–M4; [5–7]). Human STIM1 has a single transmem-
brane region [2], and oligomerizes in response to the release ofCa2+ from the EF hand domains of the extra-cytoplasmic N-termi-
nal region [9]. The cytoplasmic C-terminal region is involved in
STIM1 translocation to the ER-PM junctions and in binding to the
M4 helices of Orai1 via a region called the STIM1–Orai1 activating
region (SOAR) [10,11]. SOAR adopts a dimeric form [12], and upon
activation of the Orai1 channel STIM1 further assembles into a
higher-order oligomer using the dimer as a basic unit [13].
The CRAC channel was originally believed to consist of an Orai
tetramer, based on functional analysis of Orai1 concatemers [14],
gel electrophoresis [15,16], single-molecule photobleaching [17],
brightness analysis [18] and high-resolution electron microscopy
imaging [15]. Additionally, it was proposed that Orai1 exists as a
dimer in its inactive state and then assembles into tetramers in a
STIM1-dependent manner [16]. The STIM1/Orai1 stoichiometry of
a functional CRAC channel complex has been suggested to be either
2:4 [17] or 8:4 [19,20].
Given the wealth of evidence for a tetrameric CRAC channel, it
came as a major surprise when the crystal structure of puriﬁed
Drosophila Orai1, along with cross-linking and size exclusion chro-
matography, indicated a hexameric structure [21]. This stoichiom-
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that the deletions and mutations necessary for successful crystal
formation might have perturbed channel assembly.
We have developed a method, based on atomic force
microscopy (AFM) imaging, for determining the stoichiometry of
protein–protein interactions (e.g. [23–25]). Here, we provide evi-
dence that full-length, wild type Orai1 assembles as a hexamer,
that full-length STIM1 binds to Orai1 with sixfold symmetry, and
that STIM1/Orai1 complex formation is increased by store
depletion.2. Materials and methods
2.1. Expression, solubilization and puriﬁcation of proteins
tsA 201 cells were grown in Dulbecco’s modiﬁed Eagle’s med-
ium supplemented with 10% (v/v) fetal bovine serum, 100 lg/ml
of streptomycin and 100 units/ml of penicillin (Life Technologies,
UK). Cells were grown at 37 C, in an atmosphere of 5% CO2/air.
Human Orai1, with a C-terminal Myc/His epitope tag, and human
STIM1, with an N-terminal hemagglutinin (HA) tag were expressed
in the vector pcDNA3.1. Cells were transfected with DNA using the
calcium phosphate method. A total of 100 lg of DNA was used to
transfect 2  162 cm3 culture ﬂasks for single transfections of
either Orai1-Myc/His or HA-STIM1. For co-transfections, 50 lg of
each DNA construct was used. After transfection, cells were incu-
bated for 48 h at 37 C to allow protein expression. Transfected
cells were either untreated or treated with 5 lM thapsigargin (Life
Technologies) in the presence of 1 mM EGTA in normal extracellu-
lar solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
10 mM glucose, 10 mM HEPES, pH 7.3) for 30 min at room temper-
ature. Protein expression and intracellular localization was
checked for each condition using immunoﬂuorescence. Cells were
ﬁxed with paraformaldehyde (4% w/v), permeabilized with sapo-
nin (0.5% w/v) and incubated with appropriate antibodies: rabbit
polyclonal anti-HA (Sigma, H6908) and mouse monoclonal anti-
Myc (Life Technologies, R950-25), followed by ﬂuorescein isothio-
cyanate-conjugated goat anti-mouse and Cy3-conjugated goat
anti-rabbit (Sigma). Cells were imaged by confocal laser scanning
microscopy.
Transfected cells were solubilized in 1% Triton X-100 (v/v) for
1 h at 4 C, and the detergent extract was centrifuged at
62,000g for 1 h to remove insoluble material. During and after
solubilization, buffers contained either 2 mM Ca2+ (untreated) or
1 mM EGTA (thapsigargin-treated). To capture Orai1-Myc/His or
HA-STIM1, the solubilized extract was incubated with anti-Myc
or anti-HA agarose beads (Sigma), respectively, for 3 h. The beads
were washed extensively and bound protein was eluted with
Myc or HA peptide (100 lg/ml). The eluted samples were analyzed
by SDS–polyacrylamide gel electrophoresis (SDS–PAGE), followed
by silver staining and/or immunoblotting, using anti-Myc or anti-
HA (Covance, HA.11 clone 16B12) antibodies. In one experiment,
a sample containing Orai1-Myc/His was denatured and treated
with N-glycosidase F (25 U/ll; New England Biolabs) for 1 h at
37 C.2.2. AFM imaging
Isolated proteins were diluted to 40 pM, and 45 ll of the solu-
tion was added to a 1-cm mica disc. After 10 min, the mica was
washed with water and dried under nitrogen. Samples were
imaged in air using a Bruker Multimode atomic force microscope,
as described previously [23–25]. The silicon cantilevers (OTESPA,
Bruker) had a drive frequency of 271–321 kHz and a speciﬁed
spring constant of 12–103 N/m (Mikromasch). The scan rate was3 Hz, and the applied imaging force was kept as low as possible
(target amplitude of 1.0 V and amplitude setpoint 0.7–1.0 V).
Molecular volumes for individual STIM1 particles were deter-
mined using the Scanning Probe Image Processor Version 5 (Image
Metrology). For particles within complexes, particle heights and
radii were measured manually by the Nanoscope software. When
proteins are dried down, they ﬂatten on the mica substrate and
adopt the shape of a spherical cap. Particle volumes were therefore
calculated using the equation:
Vm ¼ ðph=6Þð3r2 þ h2Þ ð1Þ
where h is the particle height and r is the radius [26]. Molecular vol-
ume based on molecular mass was calculated using the equation:
Vc ¼ ðM0=N0ÞðV1 þ dV2Þ ð2Þ
whereM0 is the molecular mass, N0 is Avogadro’s number, V1 and V2
are the partial speciﬁc volumes of particle (0.74 cm3/g) and water
(1 cm3/g), respectively, and d is the extent of protein hydration
(taken as 0.4 g water/g protein). It has been shown previously that
there are no signiﬁcant differences in molecular volumes deter-
mined under ﬂuid and in air [26]. Further, we [27] and others
[26] have reported a very good correlation between predicted and
calculated molecular volumes for proteins of widely varying molec-
ular masses.
2.3. Analysis of binding events
AFM images were taken of complexes between Orai1 and anti-
epitope antibodies, and between Orai1 and co-expressed STIM1.
For antibody decoration, Orai1-Myc/His was incubated overnight
with either mouse monoclonal anti-His (Life Technologies; P/
N46-0693) antibody, or mouse monoclonal anti-V5 (Life Technolo-
gies; R950-25) antibody as a negative control (100 ng/ml in both
cases). To be accepted for analysis, bound antibodies needed to
have a molecular volume between 100 and 300 nm3, and bound
STIM1 particles needed to be larger than 100 nm3. Volume ranges
for STIM1 monomers and dimers were set at 100–200 nm3 and
200–300 nm3, respectively. The height of the lowest point between
the peripheral and the central particle needed to be greater than
0.3 nm for the peripheral particle to be considered bound. Any par-
ticle with a length greater than twice its width was rejected. Based
on the peaks of volume distributions for decorated central particles
(600 nm3; see results) an acceptable range was set at 400–
800 nm3. To be considered a double binding event, all particles
and both binding events needed to meet all the above criteria.
The angles between pairs of bound antibodies and STIM1 particles
were measured; a frequency distribution of angles was constructed
and the angle peaks were used to deduce the stoichiometry of the
complex. The angle peaks were broad, likely reﬂecting the fact that
the complexes attach to the mica in a variety of orientations.
Importantly, despite the ﬂattening of the particles on the mica,
the subunit arrangement within the central particle is faithfully
reported by the geometry of the complexes (e.g. [23–25]).
2.4. Statistical analysis
Histograms were drawn with bin widths chosen according to
Scott’s equation:
Bin width ¼ 3:5r=n1=3 ð3Þ
where r is an estimate of the standard deviation and n is the sample
size [28]. Where Gaussian curves were ﬁtted to the data, the num-
ber of curves was chosen to maximize the r2 value while giving sig-
niﬁcantly different means using Welch’s t test for unequal sample
sizes and unequal variances [29].
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tsA 201 cells expressing Orai1 bearing a C-terminal Myc/His
epitope tag were solubilized in Triton X-100, and protein was iso-
lated by anti-Myc immunoafﬁnity chromatography. Isolated pro-
tein was analyzed by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) followed by either silver staining, or immunoblotting
using an anti-Myc antibody. Bands were seen at 45 kDa and
50 kDa on both the silver stained gel (Fig. 1A, left panel) and
the immunoblot (right panel). After treatment of the protein with
N-glycosidase F only a single band was seen at 45 kDa (Fig. 1B)
indicating that the two original bands represent unglycosylated
and glycosylated forms of the protein.
Isolated Orai1 was imaged after incubation with an anti-His
antibody, which should decorate the C terminus of each subunit.
Low-magniﬁcation AFM images (Fig. 1C) revealed a population of
large particles, some of which were decorated by one (arrowhead),
two (arrows) or several (asterisk) smaller particles. Zoomed imagesFig. 1. Antibody decoration of Orai1 reveals a hexameric assembly state. (A) Protein
chromatography. The silver stained gel (left panel) shows bands at 45 and 50 kDa (a
Molecular mass markers (kDa) are shown. (B) Effect of N-glycosidase F treatment on the m
anti-His antibodies. The arrowhead (right panel) indicates a singly-decorated particle. Th
(left panel). The asterisk (right panel) indicates a particle decorated by six antibodies
decorated Orai1 particles. Scale bar, 20 nm; height scale, 0–3 nm. (E) Frequency distribut
the ﬁtted Gaussian function. The peak of the distribution is indicated. (F) Frequency disof large particles in various decoration states are shown in Fig. 1D.
Signiﬁcantly, the angles between pairs of bound small particles
were 60, 120 or 180. We found that 26.4% (n = 70/265) of
Orai1 particles were singly decorated; 7.3% (n = 32/438) were dou-
bly decorated, 2.5% (n = 11/438) were triply decorated and 0.7%
(n = 3/438) were decorated by 4–6 small particles. The extent of
single and double decoration by a control (anti-V5) antibody was
3.3 and 9.7 times lower, respectively, than with the positive
antibody. Further, no particles in the control were decorated by
three or more small particles. Hence, the majority of decoration
events represent speciﬁc binding of anti-His antibodies to Orai1
particles. A frequency distribution of volumes of decorated central
particles (Fig. 1E) had a single peak at 580 ± 7 nm3 (n = 129), very
close to the expected volume for an Orai1 hexamer of molecular
mass 300 kDa (570 nm3). A frequency distribution of angles
between pairs of bound antibodies (Fig. 1F) had three peaks, at
69 ± 3 (n = 40), 125 ± 5 (n = 34) and 175 ± 10 (n = 22). Angle
ranges of 30–90, 90–150 and 150–180 were set for the threewas isolated from cells expressing Orai1-Myc/His by anti-Myc immunoafﬁnity
rrows). The same bands were detected on the anti-Myc immunoblot (right panel).
obility of Orai1-Myc/His. (C) Low-magniﬁcation AFM images of Orai1 decorated by
e arrows indicate receptors doubly decorated at either 60 (right panel) or 180
. Scale bar, 200 nm; height scale, 0–4 nm. (D) Zoomed images showing antibody-
ion of molecular volumes of antibody-decorated Orai1 particles. The curve indicates
tribution of angles between pairs of bound antibodies.
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1.8:1.5:1. This angle proﬁle, with three peaks at approximately 60,
120 and 180, in a ratio of 2:2:1 indicates that the antibodies
bind the Orai1 oligomer with sixfold symmetry, and that Orai1
therefore assembles as a hexamer, consistent with the peak molec-
ular volume for the antibody-decorated particles.
Cells were next co-transfected with DNA encoding Orai1-Myc/
His and HA-STIM1. The localization of the two proteins, with and
without thapsigargin (5 lM) treatment, was determined by immu-
noﬂuorescence analysis of saponin-permeabilized cells. In control
cells, Orai1 was seen predominantly at the plasma membrane,
whereas STIM1 was found in a reticular pattern throughout the cell
cytoplasm, consistent with an ER localization (Fig. 2A). By contrast,
in thapsigargin-treated cells, the STIM1 and Orai1 signals over-
lapped extensively, consistent with the translocation of STIM1 to
sites beneath the plasma membrane [9–11]. Co-transfected cells,
either untreated or thapsigargin-treated, were solubilized, and
the detergent extracts were subjected to anti-Myc immunoprecip-
itation followed by immunoblotting with anti-Myc (Orai1) and
anti-HA (STIM1) antibodies. Orai1 was present in both samples,
as expected (Fig. 2B), whereas STIM1 was co-immunoprecipitated
only from the extract of thapsigargin-treated cells, indicating that
STIM1 associates with Orai1 only after store depletion.
A silver stained gel of protein isolated from thapsigargin-trea-
ted cells co-expressing Orai1-Myc/His and HA-STIM1 by anti-Myc
immunoafﬁnity chromatography showed prominent bands at
45 kDa and 50 kDa and a fainter band at 90 kDa (Fig. 3A, left
panel). Anti-Myc and anti-HA immunoblots (Fig. 3A, right panels)
conﬁrmed that the 45-kDa and 50-kDa bands were Orai1, and
the 90-kDa band was STIM1. Low-magniﬁcation AFM images of
the isolated sample are shown in Fig. 3B. Arrows indicate large
particles decorated by two (left panel) or three (right panel) smallFig. 2. STIM1–Orai1 interaction is triggered by Ca2+ store depletion. (A) Immuno-
ﬂuorescence detection of STIM1 and Orai1 in control and thapsigargin-treated
(5 lM, 30 min), co-transfected cells. Cells were ﬁxed, permeabilized and incubated
with rabbit polyclonal anti-HA and mouse monoclonal anti-Myc primary
antibodies, followed by ﬂuorescein isothiocyanate-conjugated goat anti-mouse and
Cy3-conjugated goat anti-rabbit secondary antibodies. Scale bar, 10 lm. (B) Co-
immunoprecipitation of STIM1 and Orai1 from control and thapsigargin-treated,
co-transfected cells. Protein was precipitated from clariﬁed detergent extracts of
cells using anti-Myc-agarose beads. Total extracts and immunoprecipitates were
analyzed by SDS–PAGE followed by immunoblotting using anti-Myc and anti-HA
antibodies.particles. Zoomed images of large particles in various decoration
states are shown in Fig. 3C. As for antibody decoration, the angles
between pairs of bound small particles were60, 120 or180.
A frequency distribution of the volumes of all bound peripheral
particles (Fig. 3D) had two peaks, at 130 ± 2 nm3 (n = 138) and
220 ± 7 nm3 (n = 43), representing STIM1 monomers and dimers,
respectively. We used a bound particle size of >100 nm3 to identify
STIM1-decorated large particles. A frequency distribution of the
decorated particles (Fig. 3E) had a single peak at 611 ± 11 nm3
(n = 134), similar to the result for antibody-decorated Orai1
(580 nm3) and to the expected volume of 570 nm3 for an Orai1
hexamer. Hence, the structures shown in Fig. 3B and C are com-
plexes between assembled Orai1 channels and STIM1. A volume
range of 400–800 nm3 was set for Orai1 channels; 16.9% (n = 71/
421) of Orai1 particles were singly decorated, 5.6% (n = 36/639)
were doubly decorated, and 1.4% (n = 9/639) were triply decorated
with STIM1; 0.3% (n = 2/639) of the Orai1 particles had >3 bound
STIM1 particles. Corresponding percentages for a control experi-
ment with no thapsigargin treatment were as follows: 8.8% (38/
431) singly decorated, 0.9% (4/431) doubly decorated and 0.2%
(1/431) triply decorated. Hence, the interaction between STIM1
and Orai1 is substantially enhanced by store depletion. In another
control experiment where Orai1 was expressed alone, 5.9% (n = 31/
525) of Orai1 particles appeared to be singly decorated and 0.6%
(n = 3/525) were doubly decorated, with no triple or multiple dec-
oration. Hence, the majority of decoration events seen represent
speciﬁc Orai1/STIM1 interactions. A frequency distribution of
angles between pairs of bound STIM1 particles (Fig. 3F) had three
peaks, at 70 ± 7 (n = 29), 130 ± 10 (n = 33) and 172 ± 12
(n = 15). Angle ranges of 30–90, 90–150 and 150–180 were set
for the three peaks; the ratio of the numbers of particles within
each peak was 1.9:2.2:1, indicating that STIM1 binds to Orai1 with
sixfold symmetry. In addition to the bound STIM1 monomers and
dimers, we also saw string-like structures, likely STIM1 oligomers,
bound to Orai1 particles (Fig. 3G). Rarely, these strings connected
multiple Orai1-sized particles to form networks (Fig. 3H).
To further address the structure of STIM1, protein was isolated
from a detergent extract of thapsigargin-treated cells expressing
HA-STIM1 (without Orai1) by anti-HA immunoafﬁnity chromatog-
raphy. A single major band was seen at 90 kDa on both a silver
stained gel (Fig. 4A, left panel) and an anti-HA immunoblot (right
panel), conﬁrming the successful isolation of the protein. A low-
magniﬁcation AFM image of the isolated protein (Fig. 4B) shows
single small particles, as well as doublets (arrowheads), and
string-like structures (arrow) similar to those described above.
Zoomed images of these two types of multimeric structures are
shown in Fig. 4C. A frequency distribution of the volumes of the
STIM1 particles (Fig. 4D) had two peaks, at 142 ± 3 nm3 (n = 249)
and 240 ± 7 nm3 (n = 82), very similar to the values for the bound
STIM1 particles (Fig. 3D).
4. Discussion
We show here that Orai1 particles decorated by either antibod-
ies or STIM1 have a molecular volume consistent with a hexameric
subunit stoichiometry. This result agrees with the reported crystal
structure of Drosophila Orai1 [21], although, signiﬁcantly, we have
used wild type, full-length Orai1, rather than the truncated and
mutated form used for crystallization. The absence of peaks repre-
senting smaller structures from the volume distribution for Orai1
isolated from quiescent cells argues against a model in which
dimers, for example, are induced to assemble into functional chan-
nels in response to STIM1 binding [16]. According to the crystal
structure, the Orai1 hexamer has sixfold symmetry at the level of
the transmembrane regions [21]. The M4 regions (amino acids
263–301) extend into the cytoplasm, and the M4 extensions of
Fig. 3. STIM1 binds to Orai1 with sixfold symmetry. (A) Protein was isolated from thapsigargin-treated cells co-expressing Orai1-Myc/His and HA-STIM1 by anti-Myc
immunoafﬁnity chromatography. The silver stained gel (left panel) shows bands at 45, 50 and 90 kDa (arrows). The immunoblots (right panel) show that the 45-kDa
and 50-kDa bands are Orai1, and the 90-kDa band is STIM1. (B) Low-magniﬁcation AFM images of Orai1 decorated by STIM1. The arrows indicate Orai1 particles decorated
by either two (left panel) or three (right panel) STIM1 particles. Scale bar, 200 nm; height scale, 0–4 nm. (C) Zoomed images showing STIM1-decorated Orai1 particles. Scale
bar, 20 nm; height scale, 0–3 nm. (D) Frequency distribution of molecular volumes of bound STIM1 particles. (E) Frequency distribution of molecular volumes of STIM1-
decorated Orai1 particles. (F) Frequency distribution of angles between pairs of bound STIM1 particles. (G) Zoomed images of Orai1 particles decorated by STIM1 strings. Scale
bar, 20 nm; height scale, 0–3 nm. (H) Zoomed images of Orai1 particles tethered together by STIM1 strings. Scale bar, 50 nm; height scale, 0–3 nm.
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Fig. 4. STIM1 appears as monomers, dimers and string-like structures. (A) Protein was isolated from thapsigargin-treated cells expressing HA-STIM1 by anti-HA
immunoafﬁnity chromatography. The silver stained gel (left panel) shows a major band at 90 kDa (arrow). The same band was detected on the anti-HA immunoblot (right
panel). (B) Low-magniﬁcation AFM image of STIM1. The arrowheads indicate STIM1 doublets; the arrow indicates a STIM1 string. Scale bar, 200 nm; height scale, 0–4 nm. (C)
Zoomed images of STIM1 doublets (upper panels) and strings (lower panels). Scale bar, 20 nm; height scale, 0–3 nm. (D) Frequency distribution of molecular volumes of
STIM1 particles.
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symmetry. Consistent with this proposed architecture, a recent
study based on NMR structural analysis of short C-terminal frag-
ments of STIM1 and Orai1 indicated that a pair of Orai1 C termini
binds one STIM1 dimer [30]. We suggest that the full-length pro-
teins investigated in the present study might behave differently.
For example, STIM1 binding may disrupt the interhelical
hydrophobic interactions, generating sixfold binding symmetry.
The sixfold symmetry of decoration of Orai1 by both antibodies
and STIM1 supports the latter possibility, and suggests that anti-
body binding might have the same effect on the M4 helix as STIM1.
In principle, the presence of the Myc/His tag at the C terminus of
Orai1 may cause structural perturbation, although the crystallized
protein was also tagged at its C terminus; further, it is known that
the Myc/His tagged Orai1 is fully functional [7], and we have
shown here that tagged Orai1 retains the ability to interact with
STIM1.
Previous studies have shown that STIM1 molecules exist as
dimers [13], and a crystal structure of the SOAR revealed a dimeric
structure [12]. There is evidence that STIM1 is functional in this
dimeric state and also interacts with Orai1 as a dimer [19]. Here,
we found that STIM1 exists predominantly as monomers, both
when expressed alone and when bound to Orai1, although both
free and bound STIM1 also contained a signiﬁcant population of
dimers, which sometimes appeared in the form of doublets. It is
possible that STIM1 dimers dissociate during the puriﬁcation pro-
cess, which might indicate a rather low-afﬁnity interaction
between the monomers. However, our results do suggest that
STIM1 monomers are capable of interacting with Orai1 hexamers.STIM1 samples also contained string-like structures that inter-
acted with, and clustered, Orai1 hexamers. A similar clustering
effect has been observed previously by negative-stain electron
microscopy, using a 107-residue CRAC activating domain of STIM1
[11]. However, the string-like structures were not seen in the pre-
vious study, likely because a STIM1 fragment was used. We suggest
that the STIM1/Orai1 network seen in our AFM images represent
remnants of the structures that assemble within cells in response
to store depletion.
In conclusion, our results reveal the hexameric assembly of full-
length, wild type Orai1, and the sixfold symmetry of the STIM1/
Orai1 complex.
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